+44 (0)20 8817 5296info@tritrials.com

Does Risk-based monitoring improve inspection readiness?

This highlights a serious concern in the gap between what the regulatory authorities are looking for from RBM and the way in which RBM is being practiced. Triumph Research Intelligence (TRI) have engaged both the MHRA and FDA during the design and development of their operational platform for quality oversight and RBM, and during those discussions heard loud and…

Read More